https://www.businesswire.com/news/home/20180530006332/en/

FARGO, N.D.--(BUSINESS WIRE)--May 30, 2018--Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron, a leading global provider of plasmid DNA manufacturing, protein production and antibody discovery services. Dr. Kania joins Michael Chambers, CEO of Aldevron; and Ethan K. Liebermann and Mark H. Carter, both from TA Associates, on the board.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180530006332/en/